PL209773A1 - Sposob wytwarzania inkluzyjnych kompleksow prostacykliny i pochodnych prostacykliny z cyklodekstrynami - Google Patents

Sposob wytwarzania inkluzyjnych kompleksow prostacykliny i pochodnych prostacykliny z cyklodekstrynami

Info

Publication number
PL209773A1
PL209773A1 PL20977378A PL20977378A PL209773A1 PL 209773 A1 PL209773 A1 PL 209773A1 PL 20977378 A PL20977378 A PL 20977378A PL 20977378 A PL20977378 A PL 20977378A PL 209773 A1 PL209773 A1 PL 209773A1
Authority
PL
Poland
Prior art keywords
prostaccline
cyclodextrins
inclusive
complexes
derivatives
Prior art date
Application number
PL20977378A
Other languages
English (en)
Other versions
PL121664B1 (en
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of PL209773A1 publication Critical patent/PL209773A1/pl
Publication of PL121664B1 publication Critical patent/PL121664B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C07D307/937Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nanotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
PL1978209773A 1977-09-23 1978-09-22 Process for preparing inclusion compounds of prostacycline and its esters with alkyls of 1 to 4 carbon atoms with cyclodextrinsna i ego alkilovykh ehfirov s 1-4 atomami uglja s ciklogekstrinami PL121664B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU77CI1770A HU179141B (pl) 1977-09-23 1977-09-23

Publications (2)

Publication Number Publication Date
PL209773A1 true PL209773A1 (pl) 1979-06-04
PL121664B1 PL121664B1 (en) 1982-05-31

Family

ID=10994670

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1978209773A PL121664B1 (en) 1977-09-23 1978-09-22 Process for preparing inclusion compounds of prostacycline and its esters with alkyls of 1 to 4 carbon atoms with cyclodextrinsna i ego alkilovykh ehfirov s 1-4 atomami uglja s ciklogekstrinami

Country Status (20)

Country Link
JP (1) JPS5456685A (pl)
AT (1) AT369362B (pl)
BE (1) BE870646A (pl)
CH (1) CH637388A5 (pl)
CS (1) CS200242B2 (pl)
DD (1) DD138600A5 (pl)
DE (1) DE2840142A1 (pl)
DK (1) DK420778A (pl)
FI (1) FI65912C (pl)
FR (1) FR2404006A1 (pl)
GB (1) GB2006193B (pl)
GR (1) GR65001B (pl)
HU (1) HU179141B (pl)
IL (1) IL55569A (pl)
IT (1) IT1160661B (pl)
NL (1) NL7809643A (pl)
PL (1) PL121664B1 (pl)
SE (1) SE447574B (pl)
SU (1) SU847914A3 (pl)
YU (1) YU220678A (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53136513A (en) * 1977-05-06 1978-11-29 Ono Pharmaceut Co Ltd Stabilization of prostaglandin-x-related compounds
US4352793A (en) * 1979-04-26 1982-10-05 Sumitomo Chemical Company, Limited Pharmaceutical composition comprising bencyclane fumarate and cyclodextrin
JPS5920230A (ja) * 1982-07-19 1984-02-01 チバ−ガイギ−・アクチエンゲゼルシヤフト ピルプロフエン含有薬剤
JPS61289034A (ja) * 1985-06-17 1986-12-19 Teijin Ltd イソカルバサイクリン類脂肪乳剤
DE3608088C2 (de) * 1986-03-07 1995-11-16 Schering Ag Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten
DE3740838A1 (de) * 1987-11-27 1989-06-08 Schering Ag Cyclodextrinclathrate von 5-cyano-prostacyclinderivaten und ihre verwendung als arzneimittel
EP1710244A4 (en) * 2004-01-29 2009-06-17 Eisai R&D Man Co Ltd METHOD FOR STABILIZING A MACROLIDE COVERAGE

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS503362B1 (pl) * 1970-06-10 1975-02-04
US3953435A (en) * 1974-01-10 1976-04-27 Ono Pharmaceutical Company Aldehyde derivatives of prostaglandins
JPS5395958A (en) * 1977-01-31 1978-08-22 Ono Pharmaceut Co Ltd Prostaglandin analogues and process for their preparation
US4178367A (en) * 1977-02-21 1979-12-11 Ono Pharmaceutical Co. Ltd. Prostaglandin I2 analogues
JPS53136513A (en) * 1977-05-06 1978-11-29 Ono Pharmaceut Co Ltd Stabilization of prostaglandin-x-related compounds

Also Published As

Publication number Publication date
GB2006193A (en) 1979-05-02
CH637388A5 (de) 1983-07-29
FI65912C (fi) 1984-08-10
FI782878A (fi) 1979-03-24
IL55569A (en) 1981-12-31
IL55569A0 (en) 1978-12-17
SU847914A3 (ru) 1981-07-15
NL7809643A (nl) 1979-03-27
PL121664B1 (en) 1982-05-31
DE2840142A1 (de) 1979-04-05
JPS5456685A (en) 1979-05-07
CS200242B2 (en) 1980-08-29
YU220678A (en) 1983-10-31
HU179141B (pl) 1982-08-28
SE7809946L (sv) 1979-03-24
AT369362B (de) 1982-12-27
BE870646A (fr) 1979-01-15
IT1160661B (it) 1987-03-11
FR2404006A1 (fr) 1979-04-20
GR65001B (en) 1980-06-12
ATA677478A (de) 1982-05-15
FI65912B (fi) 1984-04-30
IT7869160A0 (it) 1978-09-19
DD138600A5 (de) 1979-11-14
SE447574B (sv) 1986-11-24
GB2006193B (en) 1982-05-26
DK420778A (da) 1979-03-24
FR2404006B1 (pl) 1981-07-31

Similar Documents

Publication Publication Date Title
PL213015A1 (pl) Sposob wytwarzania kompleksu inkluzyjnego cyklodekstryny i indometacyny
PL204990A1 (pl) Srodek owadobojczy i roztoczobojczy oraz sposob wytwarzania podstawionych pochodnych fenoksybenzyloksykarbonylu
PL201877A1 (pl) Katalizator i sposob jego wytwarzania
BE863771A (fr) Esterastine et sa production
PL209215A1 (pl) Sposob wytwarzania analogow tiadiazolilocefalosporyn
IT1107959B (it) Alfa-azolilsolfuri e loro derivati
PL197263A1 (pl) Srodek owadobojczy i roztoczobojczy oraz sposob wytwarzania podstawionych pochodnych fenoksybenzyloksykarbonylu
PL197374A1 (pl) Sposob wytwarzania polisacharydow zawierajacych azot
IT1097833B (it) Acidi imidazolcarbossilici e loro derivati
PL204991A1 (pl) Srodek chwastobojczy oraz sposob wytwarzania pochodnych eterow czterowodorofuranu
PL208647A1 (pl) Sposob wytwarzania nowych pochodnych 5-alkilotiopirymidyny i srodek chwastobojczy
PL197371A1 (pl) Sposob wytwarzania polisacharydow zawierajacych azot
PL197372A1 (pl) Sposob wytwarzania pochodnych kanamycyny
PL215008A1 (pl) Sposob wytwarzania pochodnych piranonu-3
PL196568A1 (pl) Sposob wytwarzania nowych pochodnych kwasu amidynomrowkowego i amidynosulfinowego
PL209773A1 (pl) Sposob wytwarzania inkluzyjnych kompleksow prostacykliny i pochodnych prostacykliny z cyklodekstrynami
PL200141A1 (pl) Srodek owadobojczy,roztoczobojczy i nicieniobojczy oraz sposob wytwarzania n-sulfenylowanych karbaminianow oksymow
PL201539A1 (pl) Sposob wytwarzania maytansinolu i jego pochodnych
PL199364A1 (pl) Sposob wytwarzania nowych pochodnych benzoksycyny
IT7850879A0 (it) Derivati 25-alchilcolesterolici erelativo procedimento di produzione
PL198878A1 (pl) Sposob wytwarzania pochodnych 2-chlorosulfinyloazetydynonu
PL204533A1 (pl) Srodek chwastobojczy i sposob jego wytwarzania
PL201885A1 (pl) Sposob wytwarzania 4a-arylo-osmiowodoro-1h-2-piryndyn
PL196944A1 (pl) Srodek owadobojczy,roztoczobojczy i nicieniobojczy oraz sposob wytwarzania karbaminianow oksymow
PL204428A1 (pl) Sposob wytwarzania nowych pochodnych erytomycyny